REGENXBIO Inc. (Nasdaq: RGNX) today announced new positive interim data from the Phase I/II AFFINITY DUCHENNE trial. Updates ...

The collaboration will put together the MoxiePlex multiplex fluorescence technology with InSituPlex, Vizgen's proprietary sample preparation technique in which a mixture of antibodies are "barcoded" ...

Background Current treatments with tyrosine kinase inhibitors and immune checkpoint inhibitors have limited efficacy for ...

Lung diseases encompass a diverse range of disorders, including Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease (COPD), ...

Molecular Instruments® (MI), the inventor of the innovative HCRtm platform, and Alpenglow Biosciences, a leader in 3D light-sheet microscopy, are excited to announce a partnership that enables ...

Join 10,000+ vision professionals driving innovation in automation, AI and imaging with: Power-free contact lenses that ...

What is the likelihood that all your lysosomes could burst at the same time? Would you spontaneously dissolve? – Annika, 12, ...

Objectives Behçet disease (BD) is a complex vasculitis with both autoimmune and autoinflammatory features. Despite specific ...

Particularly, the ANA, or the antinuclear antibody test, is positive, but not always. An ANA using the immunofluorescence method is sometimes preferable to the ANA performed using ELISA (enzyme-linked ...

A new study employing novel single-cell multimodal data revealed key insights into the tumor microenvironment predictive of NSCLC treatment response.